Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goetz

Showing results (201-210 of 397) with videos related to

Pageof 40
Sort By:
Cancer Chemotherapy and Pharmacology|October 17, 2014
Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studiesJoel M Reid, Matthew P Goetz, Sarah A Buhrow, et al.
BMC Bioinformatics|July 19, 2018
HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing dataSaurabh Baheti, Xiaojia Tang, Daniel R O'Brien, et al.
Future Oncology (London, England)|April 13, 2025
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, <i>ESR1</i>-mutated, metastatic breast cancerMatthew P Goetz, Seth A Wander, Thomas Bachelot, et al.
Breast Cancer Research and Treatment|October 2, 2019
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissuesJohn R Hawse, Jodi M Carter, Kirsten G M Aspros, et al.
Pharmacogenomics|October 4, 2011
SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifenAnn M Moyer, Vera J Suman, Richard M Weinshilboum, et al.
The Oncologist|September 22, 2011
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence scoreArif H Kamal, Charles L Loprinzi, Carol Reynolds, et al.
NPJ Breast Cancer|January 25, 2019
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancerStephen Johnston, Miguel Martin, Angelo Di Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerMatthew P Goetz, David Toft, Joel Reid, et al.
Journal of the American Medical Informatics Association : JAMIA|December 6, 2011
Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical recordGuergana K Savova, Janet E Olson, Sean P Murphy, et al.
Breast Cancer Research and Treatment|January 21, 2018
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)Jame Abraham, Humberto Caldera, Robert Coleman, et al.
Pageof 40

Showing results (201-210 of 397) with videos related to

Sort By:
Pageof 40
Cancer Chemotherapy and Pharmacology|October 17, 2014
Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studiesJoel M Reid, Matthew P Goetz, Sarah A Buhrow, et al.
BMC Bioinformatics|July 19, 2018
HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing dataSaurabh Baheti, Xiaojia Tang, Daniel R O'Brien, et al.
Future Oncology (London, England)|April 13, 2025
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, <i>ESR1</i>-mutated, metastatic breast cancerMatthew P Goetz, Seth A Wander, Thomas Bachelot, et al.
Breast Cancer Research and Treatment|October 2, 2019
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissuesJohn R Hawse, Jodi M Carter, Kirsten G M Aspros, et al.
Pharmacogenomics|October 4, 2011
SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifenAnn M Moyer, Vera J Suman, Richard M Weinshilboum, et al.
The Oncologist|September 22, 2011
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence scoreArif H Kamal, Charles L Loprinzi, Carol Reynolds, et al.
NPJ Breast Cancer|January 25, 2019
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancerStephen Johnston, Miguel Martin, Angelo Di Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerMatthew P Goetz, David Toft, Joel Reid, et al.
Journal of the American Medical Informatics Association : JAMIA|December 6, 2011
Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical recordGuergana K Savova, Janet E Olson, Sean P Murphy, et al.
Breast Cancer Research and Treatment|January 21, 2018
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)Jame Abraham, Humberto Caldera, Robert Coleman, et al.
Pageof 40